Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic.

Geller, Andrew I; Lovegrove, Maribeth C; Lind, Jennifer N; Datta, S Deblina; Budnitz, Daniel S

Geller, Andrew I; Lovegrove, Maribeth C; Lind, Jennifer N; Datta, S Deblina; Budnitz, Daniel S.

Geller AI; CDC COVID-19 Response Team, Atlanta, Georgia.
Lovegrove MC; CDC COVID-19 Response Team, Atlanta, Georgia.
Lind JN; CDC COVID-19 Response Team, Atlanta, Georgia.
Datta SD; CDC COVID-19 Response Team, Atlanta, Georgia.
Budnitz DS; CDC COVID-19 Response Team, Atlanta, Georgia.

JAMA Intern Med ; 181(6): 869-872, 2021 Jun 01.

Article in English | MEDLINE | ID: covidwho-1077479

Subject(s)

Anti-Retroviral Agents/therapeutic use; COVID-19 Drug Treatment; Community Pharmacy Services/organization & administration; Drug Prescriptions/statistics & numerical data; Anti-Bacterial Agents/therapeutic use; COVID-19/epidemiology; COVID-19/prevention & control; Drug Packaging/statistics & numerical data; Humans; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Prescriptions / Community Pharmacy Services / Anti-Retroviral Agents / COVID-19 Drug Treatment Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Intern Med Year: 2021 Document Type: Article Affiliation country: Jamainternmed.2021.0299

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google